OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« Pharma News Briefs | Main | ACI "FDA Boot Camp" Conference, Boston, July 17-18 »

July 02, 2007

Hatch-Waxman Tracker Update

New cases added:

Pending cases updated:

Cases removed:

  • Diastate/Diastate AcuDial: Xcel Pharms v. Kali Labs (settled)
  • Prozac Weekly: Eli Lilly v. Barr Labs (settled)

As always, thanks to everyone who contributed information for this update!

Comments

This is great. Can you post any information about ongoing litigation between King and Lupin and the chances of Lupin winning?

It appears the FDA is now publishing a list of all Para IV certifications. (Maybe they have always done this, but if so, I didn't know about it...). They don't identify the filer, but they do give the innovator and the date of filing of the Para IV certification.


http://www.fda.gov/CDER/ogd/ppiv.htm

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.